Skip to main content

Table 2 Baseline characteristics of the responders (study population) and non-responders: Tehran Lipid and glucose study

From: External validation of the American prediction model for incident type 2 diabetes in the Iranian population

 

Responders (N = 1835)

Non-responders (N = 1008)

P-value

Sex, men

837(45.6)

466(46.2)

0.75

Age, (years)

56.02(7.89)

60.17(10.10)

< 0.0001

Body mass index, (kgm2)

28.27(4.38)

27.93(5.04)

0.07

Waist circumference, (cm)

95.21(10.33)

95.38(11.12)

0.69

Systolic blood pressure, (mmHg)

122.76(18.25)

127.4(21.55)

< 0.0001

Diastolic blood pressure, (mmHg)

77.34(10.47)

77.55(11.54)

0.62

Fasting plasma glucose, (mmol/L)

5.15(0.54)

92.96(10.07)

0.71

High density lipoprotein cholesterol, (mmol/L)

1.02(0.27)

1.03(0.27)

0.37

Triglycerides, (mmol/L)

1.72(1.12)

1.61(1.11)

0.12

Family history diabetes, (yes)

249(13.6)

125(12.4)

0.38

Follow-up duration, (years)

9.31(1.65)

9.32(1.76)

0.81

  1. Data are shown as mean (SD) for continues and number (%) for categorical covariates; IQR: Interquartile range.SD: standard deviation; IQR: interquartile range